A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Organon

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Drug: Comparator: placebo / Duration of Treatment: 16 weeks; Drug: MK0476; montelukast sodium/Duration of Treatment: 16 weeks

Study type: Interventional

Funder types: Industry

Identifiers

NCT00140946

2005_057

MK0476-075

0476-075

Details and patient eligibility

About

A study to assess the clinical effect of montelukast sodium with concomitant administration of inhaled budesonide in asthmatic patients.

Enrollment: 546 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Males or females between the ages of 18 and 70 with asthma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind